← Back
Data updated: Mar 29, 2026
IGI LABS INC
Dermatology
Generics
IGI LABS INC is a generic drug manufacturer focused on Dermatology.
1985
Since
13
Drugs
-
Trials
110
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
FUROSEMIDE 2026-01-08
NALBUPHINE HYDROCHLORIDE 2025-12-22
Labeling
NALBUPHINE HYDROCHLORIDE 2025-12-22
Labeling
MEPERIDINE HYDROCHLORIDE 2025-12-22
Labeling
MEPERIDINE HYDROCHLORIDE 2025-12-22
Labeling
MEPERIDINE HYDROCHLORIDE 2025-12-22
Labeling
MEPERIDINE HYDROCHLORIDE 2025-12-22
Labeling
MEPERIDINE HYDROCHLORIDE 2025-12-22
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 100%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Discontinued (10)
Company Info
- First Approval
- 1985-10-23
- Latest
- 2002-07-17
- Applications
- 53